Blue Venture Fund

Corporate

The Blue Venture Fund is a healthcare focused investment collaboration backed by Blue Cross Blue Shield companies, the Blue Cross Blue Shield Association, and Sandbox, with over $890m committed across four funds.

Website

Portfolio

companies

Portfolio companies

Ultromics

Ultromics develops artificial intelligence software for automated cardiovascular imaging and diagnostics.

Team

Emir Sandhu

Managing Director

Recent investments

Series B16 August 2021

£23.7M

Ultromics secures £23.7m Series B funding led by Blue Venture Fund to advance AI cardiac imaging

AI/ML MedTech

The Series B round was led by the Blue Venture Fund to accelerate the deployment of artificial intelligence in echocardiography.

"Echocardiograms uploaded to the cloud and analyzed by artificial intelligence are set to revolutionize cardiac disease treatment pathways by helping more people understand their risk of heart disease earlier and with greater accuracy,"

— Ross Upton, CEO and co-founder

Ultromics—Oxford, UK

Blue Venture Fund + 3 others